Friday, November 22, 2024
HomeTagsAnocca AB

Anocca AB

Anocca AB and Shinobi Therapeutics Announce Strategic Partnership to Develop Allogeneic TCR-T Cell Therapies in Oncology

Anocca AB (Anocca), a leading T-cell receptor-engineered T-cell (TCR-T) therapeutics company, and Shinobi Therapeutics (Shinobi), developer of immune-evasive induced pluripotent stem cell (iPSC)-derived CD8...
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics